Τρίτη 23 Ιανουαρίου 2018

EMS Stories: Community Ambulance

styker.jpg

Stryker sat down with the men and women of Community Ambulance in Las Vegas, NV. Hear their perspectives on what it's like to work in emergency medical services. For more information click here.

from EMS via xlomafota13 on Inoreader http://ift.tt/2DtGjJy
via IFTTT

EMS Stories: Community Ambulance

styker.jpg

Stryker sat down with the men and women of Community Ambulance in Las Vegas, NV. Hear their perspectives on what it's like to work in emergency medical services. For more information click here.

from EMS via xlomafota13 on Inoreader http://ift.tt/2DtGjJy
via IFTTT

EMS Stories: Community Ambulance

styker.jpg

Stryker sat down with the men and women of Community Ambulance in Las Vegas, NV. Hear their perspectives on what it's like to work in emergency medical services. For more information click here.

from EMS via xlomafota13 on Inoreader http://ift.tt/2DtGjJy
via IFTTT

EMS Stories: Community Ambulance

styker.jpg

Stryker sat down with the men and women of Community Ambulance in Las Vegas, NV. Hear their perspectives on what it's like to work in emergency medical services. For more information click here.

from EMS via xlomafota13 on Inoreader http://ift.tt/2DtGjJy
via IFTTT

Safe Life Defense gives you the chance to win their new tactical vest at SHOT Show 2018

Safe Life Defense is at SHOT SHOW 2018! Be the FIRST IN THE WORLD to win the New Tactical Vest!

from EMS via xlomafota13 on Inoreader http://ift.tt/2DxUFwn
via IFTTT

ND bill would relieve patients of air ambulance bills

The bill says that the patient's insurance company must pay the air ambulance company instead of leaving the patient with the heavy charges

from EMS via xlomafota13 on Inoreader http://ift.tt/2BmHSao
via IFTTT

Statin use and pancreatic cancer risk in two prospective cohort studies

Abstract

Background

Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated in prospective studies.

Methods

We studied the association between statin use and incident pancreatic cancer in 113,059 participants from the prospective Nurses' Health Study and Health Professionals Follow-up Study. Statin use was self-reported via study questionnaires and updated biennially. Hazard ratios (HRs) and 95% confidence intervals (CIs) for incidence of pancreatic cancer were estimated using multivariable Cox proportional hazards models with adjustment for potential confounders.

Results

In total, 583 participants developed incident pancreatic cancer during 1.4 million person-years of follow-up. No difference was identified in pancreatic cancer risk for regular versus non-regular statin users (multivariable-adjusted HR 0.98; 95% CI 0.82–1.16). There was no significant heterogeneity in the association of statin use with pancreatic cancer risk between the cohorts. Similarly, longer duration of regular statin use was not associated with decreased risk of pancreatic cancer (Ptrend = 0.65). The results remained similar when we examined statin use status at baseline or accounting for 4-year latency period. We observed no statistically significant effect modification for the association of statin use with pancreatic cancer risk by body mass index, smoking status, or diabetes mellitus status (all Pinteraction > 0.21).

Conclusions

Regular statin use was not associated with pancreatic cancer risk in two large prospective cohort studies in the U.S.



from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2G94nDp
via IFTTT